Articles
- The Protein Engineers: BioCentury
- Xencor Gets Real: BioCentury
- Fc Regions: Next Advance in Antibody Drug Research: BioWorld Today
- Xencor To Use PDA Technology To Optimize Protein In Lilly Deal: BioWorld Today
- The Protein Engineers: BioCentury
- Xencor Researchers Focus on TNF-Blocking Drugs: BioWorld Today
- Xencor Gets Real: BioCentury Technology Briefing
- Designer Cosmetics: Biotech in Personal Care: Chemical & Engineering News
- Preventive Medicine: By hook or crook, Xencor looks to take the mystery out of drug discovery: The Zone News
- Proteins In 3-D: Signals Magazine
- CEO Interview, September 2001: The Wall Street Transcript
- Designer Enzymes: The Economist
- A Kinder cure. How to spot drugs that misfire.: New Scientist Magazine
- Encouraging Entrepreneurship: Chemical & Engineering News
- Money's There, but hurdles Abound: Los Angeles Times
- Xencor Raises $12M For Computational Design Work: BioWorld Today
- Better Than Mother Nature: Forbes
- Protein Redesigned for Greater Stability: C&E News
- Caltech Prof Offers Insight Into Start-Up Success: Los Angeles Times
- No Assembly Required: Engineering and Science, Caltech, Vol 4.
- Making Proteins - Interview Bassil Dahiyat and Stephen Mayo: NPR Science Friday
- Research Shows Proteins Could Be Customized For Better Clinical Results: BioWorld Today